212 related articles for article (PubMed ID: 35534547)
1. RUNX2 recruits the NuRD(MTA1)/CRL4B complex to promote breast cancer progression and bone metastasis.
Yin X; Teng X; Ma T; Yang T; Zhang J; Huo M; Liu W; Yang Y; Yuan B; Yu H; Huang W; Wang Y
Cell Death Differ; 2022 Nov; 29(11):2203-2217. PubMed ID: 35534547
[TBL] [Abstract][Full Text] [Related]
2. CUL4B Promotes Breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway.
Huang W; Zhang J; Huo M; Gao J; Yang T; Yin X; Wang P; Leng S; Feng D; Chen Y; Yang Y; Wang Y
Adv Sci (Weinh); 2021 May; 8(10):2001515. PubMed ID: 34026424
[TBL] [Abstract][Full Text] [Related]
3. SMYD3 associates with the NuRD (MTA1/2) complex to regulate transcription and promote proliferation and invasiveness in hepatocellular carcinoma cells.
Yang Y; Qiu R; Zhao S; Shen L; Tang B; Weng Q; Xu Z; Zheng L; Chen W; Shu G; Wang Y; Zhao Z; Chen M; Ji J
BMC Biol; 2022 Dec; 20(1):294. PubMed ID: 36575438
[TBL] [Abstract][Full Text] [Related]
4. [CRL4B complex promotes the development of pancreatic cancer by inhibiting secreted frizzled related protein 1].
Chen Y; Leng S; Wang Y
Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):646-656. PubMed ID: 34289556
[No Abstract] [Full Text] [Related]
5. PHD finger protein 1 (PHF1) is a novel reader for histone H4R3 symmetric dimethylation and coordinates with PRMT5-WDR77/CRL4B complex to promote tumorigenesis.
Liu R; Gao J; Yang Y; Qiu R; Zheng Y; Huang W; Zeng Y; Hou Y; Wang S; Leng S; Feng D; Yu W; Sun G; Shi H; Teng X; Wang Y
Nucleic Acids Res; 2018 Jul; 46(13):6608-6626. PubMed ID: 29846670
[TBL] [Abstract][Full Text] [Related]
6. The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications.
Toh Y; Nicolson GL
Clin Exp Metastasis; 2009; 26(3):215-27. PubMed ID: 19116762
[TBL] [Abstract][Full Text] [Related]
7. Zinc-finger protein CXXC5 promotes breast carcinogenesis by regulating the TSC1/mTOR signaling pathway.
Wang W; Zhang Z; Zhao M; Wang Y; Ge Y; Shan L
J Biol Chem; 2023 Jan; 299(1):102812. PubMed ID: 36539038
[TBL] [Abstract][Full Text] [Related]
8. O-GlcNAc modification regulates MTA1 transcriptional activity during breast cancer cell genotoxic adaptation.
Xie X; Wu Q; Zhang K; Liu Y; Zhang N; Chen Q; Wang L; Li W; Zhang J; Liu Y
Biochim Biophys Acta Gen Subj; 2021 Aug; 1865(8):129930. PubMed ID: 34019948
[TBL] [Abstract][Full Text] [Related]
9. Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2.
Chimge NO; Baniwal SK; Little GH; Chen YB; Kahn M; Tripathy D; Borok Z; Frenkel B
Breast Cancer Res; 2011; 13(6):R127. PubMed ID: 22151997
[TBL] [Abstract][Full Text] [Related]
10. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
11. CUL4B renders breast cancer cells tamoxifen-resistant via miR-32-5p/ER-α36 axis.
Wang Y; Pan X; Li Y; Wang R; Yang Y; Jiang B; Sun G; Shao C; Wang M; Gong Y
J Pathol; 2021 Jun; 254(2):185-198. PubMed ID: 33638154
[TBL] [Abstract][Full Text] [Related]
12. The PRMT6/PARP1/CRL4B Complex Regulates the Circadian Clock and Promotes Breast Tumorigenesis.
Yang T; Huang W; Ma T; Yin X; Zhang J; Huo M; Hu T; Gao T; Liu W; Zhang D; Yu H; Teng X; Zhang M; Qin H; Yang Y; Yuan B; Wang Y
Adv Sci (Weinh); 2023 May; 10(14):e2202737. PubMed ID: 36941223
[TBL] [Abstract][Full Text] [Related]
13. The transcription factor RUNX2 fuels YAP1 signaling and gastric cancer tumorigenesis.
Guo Z; Zhou K; Wang Q; Huang Y; Ji J; Peng Y; Zhang X; Zheng T; Zhang Z; Chong D; Yang Z
Cancer Sci; 2021 Sep; 112(9):3533-3544. PubMed ID: 34160112
[TBL] [Abstract][Full Text] [Related]
14. SIRT1 coordinates with the CRL4B complex to regulate pancreatic cancer stem cells to promote tumorigenesis.
Leng S; Huang W; Chen Y; Yang Y; Feng D; Liu W; Gao T; Ren Y; Huo M; Zhang J; Yang Y; Wang Y
Cell Death Differ; 2021 Dec; 28(12):3329-3343. PubMed ID: 34163012
[TBL] [Abstract][Full Text] [Related]
15. CRL4B promotes tumorigenesis by coordinating with SUV39H1/HP1/DNMT3A in DNA methylation-based epigenetic silencing.
Yang Y; Liu R; Qiu R; Zheng Y; Huang W; Hu H; Ji Q; He H; Shang Y; Gong Y; Wang Y
Oncogene; 2015 Jan; 34(1):104-18. PubMed ID: 24292684
[TBL] [Abstract][Full Text] [Related]
16. A TGF-β-MTA1-SOX4-EZH2 signaling axis drives epithelial-mesenchymal transition in tumor metastasis.
Li L; Liu J; Xue H; Li C; Liu Q; Zhou Y; Wang T; Wang H; Qian H; Wen T
Oncogene; 2020 Mar; 39(10):2125-2139. PubMed ID: 31811272
[TBL] [Abstract][Full Text] [Related]
17. Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: role in epithelial cancer cell invasion, proliferation and nuclear regulation.
Nicolson GL; Nawa A; Toh Y; Taniguchi S; Nishimori K; Moustafa A
Clin Exp Metastasis; 2003; 20(1):19-24. PubMed ID: 12650603
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of metastasis-associated gene 1 expression affects proliferation and osteogenic differentiation of immortalized human mesenchymal stem cells.
Kumar A; Salimath BP; Schieker M; Stark GB; Finkenzeller G
Cell Prolif; 2011 Apr; 44(2):128-38. PubMed ID: 21401754
[TBL] [Abstract][Full Text] [Related]
19. RUNX2 promotes breast cancer bone metastasis by increasing integrin α5-mediated colonization.
Li XQ; Lu JT; Tan CC; Wang QS; Feng YM
Cancer Lett; 2016 Sep; 380(1):78-86. PubMed ID: 27317874
[TBL] [Abstract][Full Text] [Related]
20. Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin.
Mendoza-Villanueva D; Zeef L; Shore P
Breast Cancer Res; 2011 Oct; 13(5):R106. PubMed ID: 22032690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]